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Abstract 
PURPOSE: 
Metabolically obese but normal weight (MONW) is associated with higher risk of type 2 
diabetes, dyslipidemia, and hypertension. The aim of this study was to evaluate the 
association of metabolic syndrome components with MONW in each sex in Iranian 
population. 
METHODS: 
This cross-sectional study was performed on 417 normal weight subjects in Qazvin, Iran 
between September 2010 and April 2011. MONW was defined by insulin resistance (IR) 
using the homeostatic model assessment (HOMA). Cut off point for IR was defined as the 
lower limit of top quintile of HOMA-IR values in normal weight population without any 
metabolic risk factors. Data were analyzed using T test, Mann-Whitney U test, and multi-
variant logistic regression analysis. 
RESULTS: 
Of 417 subjects, 44.3 % were female. The prevalence of MONW was 33.8 % in men and 
39.8 % in women. Triglycerides levels were significantly higher in both men and women 
with MONW. Waist circumference was significantly higher in men with MONW, while 
high-density lipoprotein cholesterol levels were significantly lower in women with MONW. 
In logistic regression analysis, hypertriglyceridemia in women (OR 3.398; 95 % CI 1.306-
8.846) and waist circumference (per 5 cm increment) in men (OR 1.653; 95 % CI 1.279-
2.136) had independent association with MONW. 
CONCLUSION: 
Association of metabolic syndrome components with MONW is different in men and 
women. Waist circumference had an independent association with IR in men but not in 
women. IR and its complications should be considered in lean women with 
hypertriglyceridemia. 
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